Hepatocellular carcinoma (HCC) is the fifth most common cancer, but the third leading
cause of cancer death, in the world, with more than 500 000 fatalities annually. The major …

BACKGROUND/AIMS: Golgi protein-73 (GP73) is up-regulated in hepatocellular carcinoma
(HCC). The aims of this study were to determine if GP73 is detected in the serum, and to …

Background: The rising incidence of hepatocellular cancer in the US and worldwide has
sparked a renewed interest in HCC serum markers. HCC typically develops in patients with …

We report the isolation and characterization of GP73, a novel 73kDa human Golgi protein.
The GP73 cDNA was cloned by differential screening of a cDNA library derived from the liver …

GP73 is a novel type II Golgi membrane protein of unknown function that is expressed in the
hepatocytes of patients with adult giant-cell hepatitis (Gene 2000; 249: 53-65). Its expression …

OBJECTIVES GP73, a Golgi membrane protein, is expressed at high levels in hepatocytes
of patients with decompensated cirrhosis. Its expression in other forms of liver disease has …

Abstract The ACR Committee on Incidental Findings presents recommendations for
managing liver lesions that are incidentally detected on CT. These recommendations …

Prostate cancer is the most common type of tumor found in American men and is the second
leading cause of cancer death in males. To identify biomarkers that distinguish prostate …

The cis‐Golgi protein GPP130 reversibly redistributes to endosomes upon pH disruption, but
the identity of the endosomes and the involved cycling route are unknown. It is also …

A new ambulatory monitoring system was evaluated for long-term measurements of gastric
acidity. A close correlation was observed between values indicated by the pH electrode of …